Quick Answer
TENAX THERAPEUTICS, INC. reported Total Assets of $104.23 million for fiscal year 2025.
TENAX THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $104.23M | +7.8% |
| 2024 | $96.69M | +727.4% |
| 2023 | $11.69M | +243.2% |
| 2022 | $3.40M | -43.2% |
| 2021 | $5.99M | -12.8% |
| 2020 | $6.87M | +7.9% |
| 2019 | $6.37M | -52.3% |
| 2018 | $13.34M | +34.8% |
| 2017 | $9.89M | -57.6% |
| 2016 | $23.34M | -68.0% |
| 2015 | $72.99M | -12.0% |
| 2015 | $82.91M | -11.3% |
| 2014 | $93.43M | +2837.4% |
| 2013 | $3.18M | -23.2% |
| 2012 | $4.14M | +41.7% |
| 2011 | $2.92M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $102.81M | +3.0% | -2.9% |
| June 30, 2025 | $105.86M | +897.1% | -5.5% |
| March 31, 2025 | $112.06M | +674.9% | +15.9% |
| December 31, 2024 | $96.69M | +727.5% | -3.1% |
| September 30, 2024 | $99.78M | +739.3% | +839.9% |
| June 30, 2024 | $10.62M | -24.4% | -26.6% |
| March 31, 2024 | $14.46M | -5.3% | +23.8% |
| December 31, 2023 | $11.68M | +243.2% | -1.7% |
- TENAX THERAPEUTICS, INC. showed an increase of +7.8% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, TENAX THERAPEUTICS, INC.’s total assets has grown by 3466.5% (from $2.92 million to $104.23 million).
- The most recent figure is from TENAX THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: